{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:00:47Z","timestamp":1767150047736,"version":"build-2238731810"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004202","name":"Ondokuz Mayis \u00dcniversitesi","doi-asserted-by":"publisher","award":["PYO.TIP.1901.15.016"],"award-info":[{"award-number":["PYO.TIP.1901.15.016"]}],"id":[{"id":"10.13039\/501100004202","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.psyneuen.2022.105862","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T20:24:19Z","timestamp":1657139059000},"page":"105862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Increased growth hormone secretagogue receptor-1a (GHSR-1a) in hypothalamus during olanzapine treatment in rats"],"prefix":"10.1016","volume":"144","author":[{"given":"\u00d6zg\u00fcr Korhan","family":"Tun\u00e7el","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuhal","family":"Altunkaynak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bir\u015fen","family":"Bilgici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arzu","family":"Karaustao\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taner \u0130lker","family":"G\u00fcmr\u00fck\u00e7\u00fco\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2022.105862_bib1","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/jcem.86.10.7885","article-title":"Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelinlikeimmunoreactivity levels in humans","volume":"86","author":"Ariyasu","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2022.105862_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2009.03.014","article-title":"Association of adiponectin and metabolic syndrome among patients taking atypical antipsychotics for schizophrenia: a cohort study","volume":"111","author":"Bai","year":"2009","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2022.105862_bib3","first-page":"132","article-title":"Possible connection between ghrelin, resistin and TNF-alpha levels and the metabolic syndrome caused by atypical antipsychotics","author":"Birkas Kovats","year":"2005","journal-title":"Neuropsychopharmacol Hung ."},{"key":"10.1016\/j.psyneuen.2022.105862_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000113927","article-title":"Valproic acid and CEBP -mediated regulation of adipokine gene expression in hypothalamic neurons and 3T3-L1 adipocytes","volume":"88","author":"Brown","year":"2008","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.psyneuen.2022.105862_bib5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.seizure.2018.03.013","article-title":"The effects of valproate and topiramate use on serum insulin, leptin, neuropeptide Y and ghrelin levels in epileptic children","volume":"58","author":"\u00c7i\u00e7ek","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.psyneuen.2022.105862_bib6","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.pnpbp.2008.03.015","article-title":"Effects of second generation antipsychotics on leptin and ghrelin","volume":"32","author":"Danac\u0131","year":"2008","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2022.105862_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-011-2555-2","article-title":"Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters","volume":"221","author":"Davey","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psyneuen.2022.105862_bib8","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.seizure.2006.12.009","article-title":"Valproate, weight gain and carbohydrate craving: a gender study","volume":"16","author":"El-Khatib","year":"2007","journal-title":"Seizure"},{"key":"10.1016\/j.psyneuen.2022.105862_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/00048670802534341","article-title":"Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls","volume":"43","author":"Elmslie","year":"2009","journal-title":"Aust. N.Z. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2022.105862_bib10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","article-title":"Leptin and the regulation of body weight in mammals","volume":"395","author":"Friedman","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.psyneuen.2022.105862_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.schres.2018.11.036","article-title":"Meta-analysis of ghrelin alterations in schizophrenia: effects of olanzapine","volume":"206","author":"Goetz","year":"2019","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2022.105862_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1399-5618.2011.00932.x","article-title":"The burden of obesity among adults with bipolar disorder in the United States.","author":"Goldstein","year":"2011","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.psyneuen.2022.105862_bib13","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1212\/01.wnl.0000187074.27586.d1","article-title":"Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid","volume":"65","author":"Greco","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.psyneuen.2022.105862_bib14","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00228-018-2517-2","article-title":"Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder","volume":"74","author":"Grootens","year":"2018","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.psyneuen.2022.105862_bib15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.neuron.2006.08.023","article-title":"Leptin receptor signaling in midbrain dopamine neurons regulates feeding","volume":"51","author":"Hommel","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.psyneuen.2022.105862_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.psyneuen.2016.07.218","article-title":"Olanzapine-depot administration induces time-dependent changes inadipose tissue endocrine function in rats","volume":"73","author":"Horska","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2022.105862_bib17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s40618-015-0408-2","article-title":"Resistin\u2019s, obesity and insulin resistance: the continuing disconnect between rodents and humans","volume":"39","author":"Huang","year":"2016","journal-title":"Endocrinol. Investig."},{"key":"10.1016\/j.psyneuen.2022.105862_bib18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0006-8993(99)02439-7","article-title":"Sodium valproate inhibits production of TNF- \u03b1 and IL-6 and activation of NF-kB","volume":"857","author":"Ichiyama","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2022.105862_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.schres.2007.11.026","article-title":"Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin","volume":"100","author":"Jin","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psyneuen.2022.105862_bib20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.bbrc.2003.07.003","article-title":"Resistin messenger-RNA expression is increased by proinflammatory cytokines invitro","volume":"309","author":"Kaser","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.psyneuen.2022.105862_bib21","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.4088\/JCP.v64n1205","article-title":"Bipolar disorder, obesity, and pharmacotherapy-associated weight gain","volume":"64","author":"Keck","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2022.105862_bib22","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3346\/jkms.2008.23.4.685","article-title":"Body weight and plasma levels of ghrelin and leptin during treatment with olanzapine","volume":"23","author":"Kim","year":"2008","journal-title":"J. Korean Med. Sci."},{"key":"10.1016\/j.psyneuen.2022.105862_bib23","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/45230","article-title":"Ghrelin is a growth-hormone-releasing acylated peptide from stomach","volume":"402","author":"Kojima","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.psyneuen.2022.105862_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yfrne.2004.03.002","article-title":"Ghrelin\u2014a hormone with multiple functions","volume":"25","author":"Korbonits","year":"2004","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.psyneuen.2022.105862_bib25","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.1210\/en.2004-0877","article-title":"Valproic acid inhibits leptin secretion and reduces leptin messenger ribonucleic acid levels in adipocyte","volume":"145","author":"Lagace","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.psyneuen.2022.105862_bib26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-981-13-1286-1_8","article-title":"The leptin resistance","volume":"1090","author":"Liu","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.psyneuen.2022.105862_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pnpbp.2014.12.001","article-title":"Differential effects of olanzapine and clozapine on plasma levels of adipocytokines and total ghrelin","volume":"58","author":"Lu","year":"2015","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2022.105862_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neubiorev.2014.12.017","article-title":"Is there a \u201cmetabolic-mood syndrome\u201d? A review of the relationship between obesity and mood disorders","volume":"52","author":"Mansur","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.psyneuen.2022.105862_bib29","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/01.jcp.0000085403.08426.f4","article-title":"Antipsychotic-induced weight gain: bipolar disorder and leptin","volume":"23","author":"McIntyre","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2022.105862_bib30","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jad.2010.04.012","article-title":"Bipolar disorder and metabolic syndrome: an international perspective","volume":"126","author":"McIntyre","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2022.105862_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.seizure.2018.06.003","article-title":"Biochemical derangements related to metabolic syndrome in epileptic patients on treatment with valproic acid","volume":"60","author":"Nisha","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/j.psyneuen.2022.105862_bib32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/JCP.0b013e318172b8e6","article-title":"Effect of antipsychotics on peptides involved in energy balance in drug-naive psychotic patients after 1 year of treatment","volume":"28","author":"Perez-Iglesias","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2022.105862_bib33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1528-1167.2009.02307.x","article-title":"Ghrelin levels are reduced in prepubertal epileptic children under treatment with carbamazepine orvalproic acid","volume":"51","author":"Prodam","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.psyneuen.2022.105862_bib34","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1253\/circj.68.975","article-title":"Adiponectin as a biomarker of the metabolic syndrome","volume":"68","author":"Ryo","year":"2004","journal-title":"Circ. J."},{"key":"10.1016\/j.psyneuen.2022.105862_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.seizure.2017.03.007","article-title":"Evaluate the effects of long-term valproic acid treatment on metabolic profiles in newly diagnosed or untreated female epileptic patients: a prospective study","volume":"48","author":"Sidhu","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.psyneuen.2022.105862_bib36","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.bbrc.2005.06.202","article-title":"Human resistin stimulates the proinflammatory cytokines TNF-\u03b1 and IL-12 in macrophages by NF-\u03baB-dependent pathway","volume":"334","author":"Silswal","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.psyneuen.2022.105862_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114643","article-title":"Modeling of antipsychotic-induced metabolic alterations in mice: a experimental approach precluding psychosis as a predisposing factor","volume":"378","author":"Singh","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.psyneuen.2022.105862_bib38","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1128\/MCB.25.4.1569-1575.2005","article-title":"Activation of SOCS-3 by resistin","volume":"25","author":"Steppan","year":"2005","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.psyneuen.2022.105862_bib39","article-title":"Neural changes associated with appetite information processing in schizophrenic patients after 16 weeks of olanzapine treatment","volume":"19","author":"Stip","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.psyneuen.2022.105862_bib40","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.psyneuen.2015.09.026","article-title":"Are leptin levels increase damong people with schizophrenia versus controls? A systematic review and comparative meta-analysis","volume":"63","author":"Stubbs","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2022.105862_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116820","article-title":"The Global Burden of mental, neurological and substance use disorders: an analysis from the global burden of disease study 2010","volume":"10","author":"Whiteford","year":"2015","journal-title":"PLos One"},{"key":"10.1016\/j.psyneuen.2022.105862_bib42","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.psyneuen.2022.105862_bib43","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.psyneuen.2013.07.010","article-title":"The role of ghrelin signalling in second-generation antipsychotic-induced weight gain","volume":"38","author":"Zhang","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2022.105862_bib44","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1017\/S1461145713001697","article-title":"Hypothalamic ghrelin signalling mediates olanzapine-induced hyperphagia and weight gain in female rats","volume":"17","author":"Zhang","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."}],"updated-by":[{"DOI":"10.1016\/j.psyneuen.2022.105893","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"record-id":"41716"},{"DOI":"10.1016\/j.psyneuen.2022.105893","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000}}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453022002037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453022002037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T17:16:10Z","timestamp":1759684570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453022002037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":44,"alternative-id":["S0306453022002037"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2022.105862","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased growth hormone secretagogue receptor-1a (GHSR-1a) in hypothalamus during olanzapine treatment in rats","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2022.105862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105862"}}